Jessica Abrantes-Figueiredo, MD
@infectiousdiva.bsky.social
Infectious Disease Physician | Mom of 3 |Passionate about antimicrobial stewardship, infection prevention and public health | opinions my own
Reposted by Jessica Abrantes-Figueiredo, MD
Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:
See next posts
See next posts
October 22, 2025 at 1:36 PM
Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:
See next posts
See next posts
Sad to miss #IDWeek2025 but so excited to see my mentee and our work! Check out her poster (1013) @uconnid.bsky.social #IDBsky #IDsky
October 21, 2025 at 7:20 PM
Sad to miss #IDWeek2025 but so excited to see my mentee and our work! Check out her poster (1013) @uconnid.bsky.social #IDBsky #IDsky
Reposted by Jessica Abrantes-Figueiredo, MD
New from IDSA, thanks to Dr William Werbel, resp virus vax in immunocompromised population:
- vax 2 weeks before or 3-6 months after immunocompromise expected
- expect blunted response if given within that window
- defer during acute rejection, illness
- adjust for viral circulation
#IDSky #IDWeek
- vax 2 weeks before or 3-6 months after immunocompromise expected
- expect blunted response if given within that window
- defer during acute rejection, illness
- adjust for viral circulation
#IDSky #IDWeek
October 20, 2025 at 7:06 PM
Reposted by Jessica Abrantes-Figueiredo, MD
🤩 Great talks in the APP bootcamp session at #IDweek2025
Back to basics sure, but contextualized by high quality presenters = 🙌
Back to basics sure, but contextualized by high quality presenters = 🙌
October 19, 2025 at 3:23 PM
🤩 Great talks in the APP bootcamp session at #IDweek2025
Back to basics sure, but contextualized by high quality presenters = 🙌
Back to basics sure, but contextualized by high quality presenters = 🙌
In keeping with spooky 💀🎃👻 season, these are some scary do not miss diagnoses! Did you catch them all? #IDBsky #IDsky @uconnid.bsky.social
October 19, 2025 at 11:21 PM
In keeping with spooky 💀🎃👻 season, these are some scary do not miss diagnoses! Did you catch them all? #IDBsky #IDsky @uconnid.bsky.social
Reposted by Jessica Abrantes-Figueiredo, MD
🥳🎉
October 19, 2025 at 7:41 PM
🥳🎉
Reposted by Jessica Abrantes-Figueiredo, MD
Just me waiting on #IDweek2025 posts so I can pretend like I’m there too
😂😬👀
😂😬👀
a man is sitting on a swing and saying patiently waiting .
ALT: a man is sitting on a swing and saying patiently waiting .
media.tenor.com
October 19, 2025 at 3:35 PM
Just me waiting on #IDweek2025 posts so I can pretend like I’m there too
😂😬👀
😂😬👀
Reposted by Jessica Abrantes-Figueiredo, MD
🆕🔥🔥CloCeBa RCT
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
October 19, 2025 at 4:34 AM
🆕🔥🔥CloCeBa RCT
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Reposted by Jessica Abrantes-Figueiredo, MD
October 18, 2025 at 1:17 PM
Reposted by Jessica Abrantes-Figueiredo, MD
This week @infectiousdiva.bsky.social (aka Dr. Abrantes) joined in on some escape room fun. Brought to you by the Infection Prevention and Simlab Teams to start celebrating International Infection Prevention Week! 🕵🏻♀️🦠
October 16, 2025 at 11:58 PM
This week @infectiousdiva.bsky.social (aka Dr. Abrantes) joined in on some escape room fun. Brought to you by the Infection Prevention and Simlab Teams to start celebrating International Infection Prevention Week! 🕵🏻♀️🦠
Nothing spookier 👻 than respiratory season! Stay protected and protect others! #IDsky @uconnid.bsky.social
October 14, 2025 at 3:50 PM
Nothing spookier 👻 than respiratory season! Stay protected and protect others! #IDsky @uconnid.bsky.social
Reposted by Jessica Abrantes-Figueiredo, MD
October 12, 2025 at 3:33 PM
It’s Spooky Season 🎃👻
Here are some ID emergencies you should not miss and work-up/empiric treatments to remember! #IDSky @uconnid.bsky.social
Here are some ID emergencies you should not miss and work-up/empiric treatments to remember! #IDSky @uconnid.bsky.social
October 12, 2025 at 11:17 PM
It’s Spooky Season 🎃👻
Here are some ID emergencies you should not miss and work-up/empiric treatments to remember! #IDSky @uconnid.bsky.social
Here are some ID emergencies you should not miss and work-up/empiric treatments to remember! #IDSky @uconnid.bsky.social
October 12, 2025 at 1:44 PM
October 11, 2025 at 9:44 PM
Highly bioavailable drugs to know! 💊
Remember:
📍 IV is not superior to PO as long as patient improved and gut working
📍IV to PO transition is just that: a transition. Sometimes using the word de-escalation suggests it’s inferior.
📍Don’t forget shorter is better
#IDSky @uconnid.bsky.social
Remember:
📍 IV is not superior to PO as long as patient improved and gut working
📍IV to PO transition is just that: a transition. Sometimes using the word de-escalation suggests it’s inferior.
📍Don’t forget shorter is better
#IDSky @uconnid.bsky.social
October 11, 2025 at 8:54 PM
Highly bioavailable drugs to know! 💊
Remember:
📍 IV is not superior to PO as long as patient improved and gut working
📍IV to PO transition is just that: a transition. Sometimes using the word de-escalation suggests it’s inferior.
📍Don’t forget shorter is better
#IDSky @uconnid.bsky.social
Remember:
📍 IV is not superior to PO as long as patient improved and gut working
📍IV to PO transition is just that: a transition. Sometimes using the word de-escalation suggests it’s inferior.
📍Don’t forget shorter is better
#IDSky @uconnid.bsky.social
✨ Here we have Recurrent UTI ✨ @uconnid.bsky.social
October 9, 2025 at 5:38 PM
✨ Here we have Recurrent UTI ✨ @uconnid.bsky.social
Let’s start with UTI 🦠 #infectiousdisease #medstudent #uti #antibiotics #medicine #internalmedicine #shorterisbetter
October 9, 2025 at 1:15 AM
Let’s start with UTI 🦠 #infectiousdisease #medstudent #uti #antibiotics #medicine #internalmedicine #shorterisbetter
Ever wonder how to make the most out of your ID rotation? Here are a few tips! 🦠👩🏻⚕️🧫 #infectiousdisease #medstudent #resident #fellow #medicine #hospital #bugsanddrugs
October 9, 2025 at 1:10 AM
Ever wonder how to make the most out of your ID rotation? Here are a few tips! 🦠👩🏻⚕️🧫 #infectiousdisease #medstudent #resident #fellow #medicine #hospital #bugsanddrugs
Here’s a few tips and trips I wish all providers knew 🙃
October 9, 2025 at 1:05 AM
Here’s a few tips and trips I wish all providers knew 🙃
Hi Bluesky! Taking my social media onto this platform as well. If you love all things ID, antimicrobial stewardship, infection prevention and teaching then give a follow 🥰 Oh and hopefully you get a few good laughs too 🤣
October 9, 2025 at 1:02 AM
Hi Bluesky! Taking my social media onto this platform as well. If you love all things ID, antimicrobial stewardship, infection prevention and teaching then give a follow 🥰 Oh and hopefully you get a few good laughs too 🤣